The goal of this observational study is to make a statement concerning the identification of depressive symptoms at the time of the realization of the G8 score in patients over 75 with cancer and followed in oncology.

The main question it aims to answer are:

• Compare the medical hetero-evaluation of depressive symptoms via the G8 "neuro-psychiatric disorders" item score with a self-evaluation via the GDS-15 score
• Evaluate the number of patients over 75 treated with antidepressants
• Evaluate the proportion of patients with depressive symptoms according to the predisposing factors
• Compare the number of patients followed in oncogeriatrics over the period from 01/01/2022 to 02/28/2022 and the period from 01/01/2023 to 02/28/2023

Participants will complete a self-questionnaire (GDS-15 score) as well as a socio-demographic sheet.

Inclusion Criteria:

• Patients aged 75 and over
• Patients receiving treatment at the day hospital or oncology week hospital
• Patients informed and having not presented any opposition to their participation

Exclusion Criteria:

• Patients under the age of 75
• Patients under guardianship or curatorship
• Patients without social security
• Cognitive disorders compromising the understanding of the information and the performance of the study (in particular the completion of a self-administered questionnaire), in the opinion of the oncologist

All patients over 75 presenting eligibility criteria and undergoing oncological treatment and coming for consultation in the Hôpital Nord Franche-Comté